STIL overexpression shortens lifespan and reduces tumor formation in mice.


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
28 Oct 2024
Historique:
received: 19 06 2024
accepted: 14 10 2024
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 28 10 2024
Statut: aheadofprint

Résumé

Centrosomes are the major microtubule organizing centers of animal cells. Supernumerary centrosomes are a common feature of human tumors and associated with karyotype abnormalities and aggressive disease, but whether they are cause or consequence of cancer remains controversial. Here, we analyzed the consequences of centrosome amplification by generating transgenic mice in which centrosome numbers can be increased by overexpression of the structural centrosome protein STIL. We show that STIL overexpression induces centrosome amplification and aneuploidy, leading to senescence, apoptosis, and impaired proliferation in mouse embryonic fibroblasts, and microcephaly with increased perinatal lethality and shortened lifespan in mice. Importantly, both overall tumor formation in mice with constitutive, global STIL overexpression and chemical skin carcinogenesis in animals with inducible, skin-specific STIL overexpression were reduced, an effect that was not rescued by concomitant interference with p53 function. These results suggest that supernumerary centrosomes impair proliferation in vitro as well as in vivo, resulting in reduced lifespan and delayed spontaneous as well as carcinogen-induced tumor formation.

Identifiants

pubmed: 39466849
doi: 10.1371/journal.pgen.1011460
pii: PGENETICS-D-24-00677
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011460

Informations de copyright

Copyright: © 2024 Moussa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Amira-Talaat Moussa (AT)

Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
Department of Pathology, Faculty of Veterinary Medicine, Zagazig University, Al Sharkia, Egypt.

Marco R Cosenza (MR)

Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.

Timothy Wohlfromm (T)

Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.

Katharina Brobeil (K)

Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.

Anthony Hill (A)

Schaller Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Annarita Patrizi (A)

Schaller Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Karin Müller-Decker (K)

Core Facility Tumor Models, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Tim Holland-Letz (T)

Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Anna Jauch (A)

Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.

Bianca Kraft (B)

Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.

Alwin Krämer (A)

Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.

Classifications MeSH